Piper Sandler downgrades Biogen, cuts PT by $177 on account of transition challenges By Investing.com
Investing.com -- Piper Sandler lowered Biogen Inc's (NASDAQ:) ranking from 'obese' to…
Trump 2.0 is a ‘recipe for volatility’ in 2025, says Piper By Investing.com
Investing.com -- Donald Trump's return to the White Home may result in…